Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Jinhua Xu, Zhenghua Zhang et al.|Journal of the American Academy of Dermatology|2024Cited by 28
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancerYansong Liu, Fei Ma, Mingcui Li et al.|Cancer Immunology Immunotherapy|2024Cited by 8